Carcinoembryonic antigen (CEA) is highly expressed in patients with pancreatic cancer, gastric cancer and colorectal cancer, but its diagnostic specificity for pancreatic cancer is poor (18). This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.